Literature DB >> 18212023

The acetate recovery factor to correct tracer-derived dietary fat oxidation in humans.

Audrey Bergouignan1, Dale A Schoeller, Susanne Votruba, Chantal Simon, Stéphane Blanc.   

Abstract

When using (13)C tracer to measure plasma fat oxidation, an acetate recovery factor should be determined in every subject to correct for label sequestration. Less is known regarding the acetate recovery factor for dietary fatty acid oxidation. We compiled data from six studies to investigate the determinants of the dietary acetate recovery factor (dARF) at rest and after physical activity interventions and compared the effects of different methods of dARF calculation on both the fat oxidation and its variability. In healthy lean subjects, dARF was 50.6 +/- 5.4% dose (n = 56) with an interindividual coefficient of variation of 10.6% at rest and 9.2% after physical activity modifications. The physical activity interventions did not impact dARF, and the intraindividual coefficient of variation was 4.6%. No major anthropological or physiological determinants were detected except for resting metabolic rate, which explains 7.4% of the dARF variability. Applying an individual or an average group dARF did not affect the mean and the variability of the derived dietary lipid oxidation at rest or after physical activity interventions. Using a mean dARF for a group leads to over- or underestimation of fat oxidation of less than 10% in individual subjects. Moreover, the use of a group or individual correction did not affect the significant relationship found between fasting respiratory exchange ratio and dietary fat oxidation. These data indicate that an average dARF can be applied for longitudinal and cross-sectional studies investigating dietary lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212023     DOI: 10.1152/ajpendo.00720.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  8 in total

1.  Exercise training improves fat metabolism independent of total energy expenditure in sedentary overweight men, but does not restore lean metabolic phenotype.

Authors:  E Lefai; S Blanc; I Momken; E Antoun; I Chery; A Zahariev; L Gabert; A Bergouignan; C Simon
Journal:  Int J Obes (Lond)       Date:  2017-07-03       Impact factor: 5.095

2.  Measuring plasma fatty acid oxidation with intravenous bolus injection of 3H- and 14C-fatty acid.

Authors:  Christina Koutsari; Asem H Ali; Manpreet S Mundi; Michael D Jensen
Journal:  J Lipid Res       Date:  2012-10-23       Impact factor: 5.922

3.  Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects.

Authors:  François Normand-Lauzière; Frédérique Frisch; Sébastien M Labbé; Patrick Bherer; René Gagnon; Stephen C Cunnane; André C Carpentier
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

4.  Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation?

Authors:  Leanne Hodson; Siobhán E McQuaid; Sandy M Humphreys; Ross Milne; Barbara A Fielding; Keith N Frayn; Fredrik Karpe
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-13       Impact factor: 4.310

5.  Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men.

Authors:  Camilla Pramfalk; Michael Pavlides; Rajarshi Banerjee; Catriona A McNeil; Stefan Neubauer; Fredrik Karpe; Leanne Hodson
Journal:  J Clin Endocrinol Metab       Date:  2015-09-28       Impact factor: 5.958

6.  Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: A palmitate breath test study.

Authors:  Gihan Naguib; Nevitt Morris; Shanna Yang; Nancy Fryzek; Vanessa Haynes-Williams; Wen-Chun A Huang; Jaha Norman-Wheeler; Yaron Rotman
Journal:  Liver Int       Date:  2019-12-15       Impact factor: 8.754

7.  Physical inactivity differentially alters dietary oleate and palmitate trafficking.

Authors:  Audrey Bergouignan; Guy Trudel; Chantal Simon; Angèle Chopard; Dale A Schoeller; Iman Momken; Susanne B Votruba; Michel Desage; Graham C Burdge; Guillemette Gauquelin-Koch; Sylvie Normand; Stéphane Blanc
Journal:  Diabetes       Date:  2008-11-18       Impact factor: 9.461

8.  Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.

Authors:  Charlotte J Green; Camilla Pramfalk; Catriona A Charlton; Pippa J Gunn; Thomas Cornfield; Michael Pavlides; Fredrik Karpe; Leanne Hodson
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.